SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement

Rhea-AI Summary

SOHM Inc (OTC:SHMN), a pharmaceutical and biotechnology company, has launched its redesigned website at SOHM.com. The new website features improved navigation, enhanced product information, and comprehensive investor resources.

Key improvements include an intuitive user interface, detailed product ordering capabilities, updated information about their ABBIE genome editing platform, and expanded investor relations materials. Additionally, the company announced plans to launch an e-commerce platform at store.sohm.com in the coming days to support their B2C strategy for cosmeceuticals, nutraceuticals, and OTC products.

CHINO HILLS, CALIFORNIA / ACCESS Newswire / July 21, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading innovator in pharmaceuticals, nutraceuticals, topicals, and biotechnology, is excited to announce the launch of its newly designed website, now live at SOHM.com (https://sohm.com). This refreshed online presence aims to better serve customers, collaborators, and investors with an intuitive interface, improved navigation, more information, and enhanced features.

The new website showcases SOHM's commitment to transparency and accessibility. Visitors will find a wealth of information about SOHM's mission, vision, and innovative products and services. The site also offers valuable resources, including company information, product and service materials, greater information about ABBIE genome editing, and investor relations updates such as the SOHM Financial Reports and other corporate events.

Key features of the new website include:

• User-Friendly Design: An intuitive layout to help users find the information they need quickly and easily.

• More Product and Service Information: Product and service materials are easier to access and provide faster methods for ordering.

• Updated ABBIE Information: New materials on this exciting genome editing platform.

• Investor Materials: Comprehensive information tailored specifically for investors, including annual reports and shareholder information.

"We are thrilled to unveil our new website, which reflects our dedication to growth, innovation, and customer satisfaction," said Dr, David Aguilar, PhD, COO of SOHM, Inc. "We believe that this updated platform will enhance our ability to connect with our customers and partners while providing the information they need in a more effective and visually enhanced manner."

Furthermore, Dr. Aguilar mentioned that our new e-commerce website, https://store.sohm.com, is expected to go live in the next few days. This launch will significantly support our B2C strategy for cosmeceuticals, nutraceuticals, and OTC products.

SOHM, Inc. invites everyone to visit SOHM.com (http://sohm.com) and explore the new website. The company looks forward to engaging in more deeply with its community and providing enhanced services through this digital transformation.

About SOHM, Inc.:

SOHM is a biopharmaceutical company dedicated to developing and commercializing gene editing technologies for research, synthetic biology, and therapeutic applications. With a focus on precision medicine, SOHM aims to revolutionize the treatment of genetic diseases by providing safe, efficient, and targeted solutions for gene editing. Through strategic collaborations and groundbreaking research, SOHM is at the forefront of advancing the field of gene therapy. SOHM strives to transform the landscape of genome editing and improve the quality of life through scientific discovery.

For further information regarding this announcement or to explore potential collaborations, please contact:

SOHM, Inc.:
Name: Baron Night, CEO/Dr. David Aguilar, COO
Email: info@sohm.com
Phone: (714) 522-6700

Safe Harbor Statement:

This news release contains "forward-looking statements," which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.

SOURCE: SOHM, Inc

View the original press release on ACCESS Newswire

FAQ

What new features are included in SOHM's (SHMN) redesigned website?

The new website includes a user-friendly design with intuitive navigation, enhanced product information and ordering capabilities, updated ABBIE genome editing platform details, and comprehensive investor materials including annual reports.

When will SOHM's (SHMN) e-commerce website launch?

SOHM's e-commerce website at store.sohm.com is expected to launch within the next few days following the July 21, 2025 announcement.

What products will be available on SOHM's (SHMN) new e-commerce platform?

The e-commerce platform will support SOHM's B2C strategy for cosmeceuticals, nutraceuticals, and OTC products.

Where can investors find SOHM (SHMN) financial reports and corporate information?

Investors can access SOHM's financial reports and corporate information through the investor relations section of the newly launched website at SOHM.com.